December 15, 2025-December 16, 2025 Complex in Vitro Model Qualification Framework Public Workshop #3 C-Path's Predictive Safety Testing consortium (PSTC) is proud to announce the third public workshop on evidentiary...
September 4, 2025 C-Path’s Translational Therapeutics Accelerator Marks Record Year with Seven BRIDGe Awards Advancing Potential Therapies Across Cancer, Infectious Disease, Neurology and Immunology Program launched in 2022 has grown into a global pipeline partner for academic teams, awarding approximately $2.48 million in 2025
September 4, 2025 From Data to Hope: C-Path’s Polycystic Kidney Disease Outcomes Consortium and the Power of Data Sharing Every year on September 4, families, patients, advocates, and researchers come together to recognize Polycystic Kidney Disease...
September 8, 2025 Shaping the Future of AATD: Patient Perspectives to Drive the Next Decade of Innovation in Alpha-1 Antitrypsin Deficiency On September 8, C-Path and the Alpha-1 Foundation are co-hosting a virtual workshop, Shaping the Future of AATD: Patient...
August 21, 2025 HDYO Joins C-Path’s Huntington’s Disease Consortium to Amplify Youth Voices in Drug Development TUCSON, Ariz., August 21, 2025 — Critical Path Institute’s® (C-Path) Huntington’s Disease Regulatory Science Consortium (HD
August 19, 2025 C-Path’s Translational Therapeutics Accelerator Announces $473,000 Grant for Drug Development Project in Primary Sclerosing Cholangitis TUCSON, Ariz, August 19, 2025 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) has awarded a
August 14, 2025 Honoring Our Partners on National Nonprofit Day: Celebrating 20 Years of Advancing Regulatory Science at C-Path Sunday, August 17, represents National Nonprofit Day, a time to recognize the profound impact that nonprofit organizations have on
August 7, 2025 C-Path Awards Translational Therapeutics Accelerator Grant to Advance First-in-Class Antibiotic for Drug-Resistant Lung Infections TUCSON, Ariz., Aug. 7, 2025 ⎯ Critical Path Institute® (C-Path) announced today that its Translational Therapeutics Accelerator
August 7, 2025 Critical Path Institute’s Translational Therapeutics Accelerator Awards $150,000 Grant to Support a Novel Drug Approach in Hereditary Spastic Paraplegia TUCSON, Ariz., August 7, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) has awarded
July 23, 2025 The Critical Path Institute Podcast: eCOA Conversations on Digital Health Technologies This newest podcast episode from Critical Path Institute’s® (C-Path) Electronic Clinical Outcome Assessment (eCOA) Consortium..